This content is machine translated Chronic pruritus: “Tour d'horizon” Focus on new anti-inflammatory therapeutic approaches Chronic pruritus is associated with considerable suffering and can occur both as part of classic dermatoses and as a leading symptom of many internal diseases. In chronic prurigo, long-lasting itching...…
View Post 6 min This content is machine translated Biologics for plaque psoriasis What increases the chance of a sustained remission? State-of-the-art technologies now make it possible to decipher the aetiopathogenesis of skin diseases at a molecular level, which can be used to optimize treatment strategies. In plaque psoriasis – a...…
View Post 10 min This content is machine translated Atopic dermatitis in children New secondary analysis on dietary interventions A task force of the European Academy of Allergology and Clinical Immunology (EAACI) has compiled the current evidence on dietary interventions in pediatric AD patients who do not have food...…
View Post 7 min This content is machine translated Spinaliomas and basal cell carcinomas New therapeutic targets in the sights of research Cutaneous squamous cell carcinoma and basal cell carcinoma account for 99% of all cases of non-melanocytic skin cancer (NMSC). Based on an increasing understanding of the pathomechanisms that play a...…
View Post 16 min This content is machine translated Blastic plasmacytoid dendritic cell neoplasia Rare malignancy from a dermatological perspective Blastic plasmacytoid dendritic cell neoplasia (BPDCN) is an aggressive hematologic malignancy originating from immature plasmacytoid dendritic cell (PDC) precursors. The initial manifestation of BPDCN often consists of cutaneous lesions. In...… CME-Test
View Post 6 min This content is machine translated Hair loss Controversy over the benefits of biotin supplementation: what is evidence-based? Biotin, also known as “vitamin B7”, is sometimes referred to as “vitamin H” in reference to the terms “hair and skin”. There are many myths surrounding the question of whether...…
View Post 10 min This content is machine translated Cutaneous lupus erythematosus From diagnostic workup to successful treatment Cutaneous lupus erythematosus (CLE) is a rare autoimmune disease with a heterogeneous spectrum of clinical manifestations on the skin. Prof. Dr. med. Luca Borradori, Chief Physician and Clinic Director of...…
View Post 7 min This content is machine translated Moderate to severe chronic hand eczema Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland In the phase III DELTA 1 and 2 studies, delgocitinib cream showed a rapid onset of efficacy – at week 16, half of the patients achieved a 75% improvement in...…
View Post 4 min This content is machine translated Prurigo nodularis Retrospective analyses of large data sets from everyday practice Prurigo nodularis (PN) is a chronic inflammatory skin disease that manifests itself as extremely itchy hard nodules. Prof. Dr. med. Dr. rer nat. Enno Schmidt from the University Hospital Schleswig-Holstein...…
View Post 4 min This content is machine translated Oral JAK-i in atopic dermatitis Benefits and risks: What does the current data say? Although there have been no recent approvals of oral JAK inhibitors (JAK-i) for atopic dermatitis (AD), some interesting study findings have been published. These shed light on the safety of...…
View Post 4 min This content is machine translated Biologics for atopic dermatitis Th2 cytokines in focus: proven and new targets The range of antibody therapies for atopic dermatitis (AD) has expanded once again in Europe. In addition to dupilumab and tralokinumab, lebrikizumab is another biologic available in this country that...…
